Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment
- PMID: 27748053
- PMCID: PMC5119965
- DOI: 10.1002/cam4.917
Hepatocellular carcinoma in children and young patients with chronic HBV infection and the usefulness of alpha-fetoprotein assessment
Abstract
The aims of the study were to elucidate the clinical characteristics of patients who developed hepatocellular carcinoma (HCC) related to persistent HBV infection since childhood and to investigate usefulness of assessing alpha-fetoprotein (AFP) in this population. A nationwide multicenter survey of children with chronic HBV infection was performed. Among 548 patients, 15 patients developed HCC at the median age of 15 years (range 9-36), including 13 males and 2 females. A case-control comparison showed that HBeAg seroconversion and liver cirrhosis were associated with the occurrence of HCC. Of the 15 HCC patients, 5 were treated with interferon and none of them responded to interferon therapy as compared with 12 of the 17 responders in the control group. Of the 15 patients, 10 died and 9 of the 10 who died never visited any medical facilities until diagnosis of HCC, while the remaining 5 surviving patients never stopped their clinic visits. The usefulness of AFP assessment was shown by the findings that AFP levels were elevated in all HCC cases, that elevations in AFP levels were detected prior to the diagnosis in the surviving patients, and that sensitivity of AFP as a diagnostic test for HCC was very high among 40 patients including our 14 and an additional 26 collected from the literature. HBeAg seroconversion and liver cirrhosis are associated with the occurrence of HCC. Regular measurement of AFP might be helpful to watch for the occurrence of HCC when following children and young patients with chronic HBV infection since childhood.
Keywords: HBeAg seroconversion; alpha-fetoprotein; hepatocellular carcinoma; interferon; liver cirrhosis.
© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures
Similar articles
-
Elevated serum soluble CD14 levels in chronic HBV infection are significantly associated with HBV-related hepatocellular carcinoma.Tumour Biol. 2016 May;37(5):6607-17. doi: 10.1007/s13277-015-4423-x. Epub 2015 Dec 7. Tumour Biol. 2016. PMID: 26643893
-
Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.PLoS One. 2016 Apr 12;11(4):e0153227. doi: 10.1371/journal.pone.0153227. eCollection 2016. PLoS One. 2016. PMID: 27070780 Free PMC article.
-
Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.Cancer Med. 2020 May;9(9):3057-3069. doi: 10.1002/cam4.2968. Epub 2020 Mar 9. Cancer Med. 2020. PMID: 32150664 Free PMC article.
-
Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.Semin Liver Dis. 2005;25 Suppl 1:40-7. doi: 10.1055/s-2005-915649. Semin Liver Dis. 2005. PMID: 16103980 Review.
-
Prevention of hepatocellular carcinoma in hepatitis B virus infection.J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x. J Gastroenterol Hepatol. 2009. PMID: 19702903 Review.
Cited by
-
Benefits and Risks of Antiviral Treatment during Pregnancy in Patients with Chronic Hepatitis B.J Clin Med. 2021 May 26;10(11):2320. doi: 10.3390/jcm10112320. J Clin Med. 2021. PMID: 34073357 Free PMC article. Review.
-
Hepatitis B Virus Seropositivity Is a Poor Prognostic Factor of Pediatric Hepatocellular Carcinoma: a Population-Based Study in Hong Kong and Singapore.Front Oncol. 2020 Nov 20;10:570479. doi: 10.3389/fonc.2020.570479. eCollection 2020. Front Oncol. 2020. PMID: 33330043 Free PMC article.
-
Pediatric Primary Hepatic Tumors: Diagnostic Considerations.Diagnostics (Basel). 2021 Feb 18;11(2):333. doi: 10.3390/diagnostics11020333. Diagnostics (Basel). 2021. PMID: 33670452 Free PMC article. Review.
-
Hepatocellular Carcinoma of Fibrolamellar Type in an Adolescent: Case Report and Literature Review.Gastrointest Tumors. 2019 Aug;6(1-2):43-50. doi: 10.1159/000499581. Epub 2019 May 27. Gastrointest Tumors. 2019. PMID: 31602376 Free PMC article.
-
Genetic correction of serum AFP level improves risk prediction of primary hepatocellular carcinoma in the Dongfeng-Tongji cohort study.Cancer Med. 2018 Jun;7(6):2691-2698. doi: 10.1002/cam4.1481. Epub 2018 Apr 25. Cancer Med. 2018. PMID: 29696820 Free PMC article.
References
-
- Yeung, Y. P. , Lo C. M., Liu C. L., Wong B. C., Fan S. T., and Wong J.. 2005. Natural history of untreated nonsurgical hepatocellular carcinoma. Am. J. Gastroenterol. 100:1995–2004. - PubMed
-
- Darbari, A. , Sabin K. M., Shapiro C. N., and Schwarz K. B.. 2003. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 38:560–566. - PubMed
-
- Sokal, E. M. , Paganelli M., Wirth S., Socha P., Vajro P., Lacaille F., et al. 2013. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines. J. Hepatol. 59:814–829. - PubMed
-
- Ni, Y. H. , Chang M. H., Hsu H. Y., Hsu H. C., Chen C. C., Chen W. J., et al. 1991. Hepatocellular carcinoma in childhood. Clinical manifestations and prognosis. Cancer 68:1737–1741. - PubMed
-
- Chen, J. C. , Chen C. C., Chen W. J., Lai H. S., Hung W. T., and Lee P. H.. 1998. Hepatocellular carcinoma in children: clinical review and comparison with adult cases. J. Pediatr. Surg. 33:1350–1354. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical